Jun 2, 2021|
JD Health and Sanofi China Expand Collaboration on Digitalized Services
by Vivian Yang
JD Health and Sanofi China will expand their existing collaboration to building general and digitalized health management solutions for patients with chronic diseases in China, as announced on Jun. 1.
Based on the “internet + healthcare” model, the cooperation aims to benefit more patients across the country with premier medical services and relieve pressure on the overloaded public medical system.
Under the new agreement, the two companies will work together in five main areas: prescription medicines, vaccines, consumer health products, medical services and commercial insurance, covering extensive medical services prior, during and after diagnosis, and will explore innovations in medical payments to improve patients’ overall telemedicine usage experience.
Leveraging digital technologies including AI, big data, IoT and more, the collaboration seeks to address the current challenges surrounding telemedicine services such as users’ lack of trust in telemedicine doctors, doctors’ response speed to online queries, and how personalized their feedback can be, as well as concerns as to the source, quality and transportation safety of medicines ordered online.
“As an industry precursor under the country’s ‘Digital China’ blueprint in the 14th Five-Year Plan, Sanofi China is accelerating our own digital transformation and adopting various digital innovations to improve patients’ prognosis, committing to building a higher level digitalized medical ecosystem,” said Dr. Pius S. Hornstein, country lead, Sanofi China. “JD Health’s excellent service capabilities and complete ecosystem in these areas give a good push for this cooperation to offer all-round support to customers in China.”
Lijun Xin, CEO of JD Health noted that “JD Health is an integrated ‘internet +healthcare” platform combining both online and offline services. We hope to bring in all kinds of chronic disease management service abilities on this platform in order to create diversified service experience for our customers. JD Health and Sanofi have great potential to collaborate further in this area. Both sides will pool premier resources together to advance the establishment of integrated healthcare solutions including disease prevention, diagnosis, treatment, rehabilitation, follow-up cares and more, promoting the standardization of the ‘internet+healthcare’ industry.”
Since October 2020, JD Health and Sanofi China have cooperated on providing comprehensive services for diabetes treatment and management, spanning online medical consultations, prescription refills, cold chain distribution of insulin, blood glucose management, and diabetes education. A number of Sanofi’s cold chain medicines, such as Lantus and Dupixent, are available online via JD Pharmacy and distributed to patients nationwide through JD’s proprietary cold chain network.
Banner photo: Dr. Pius S. Hornstein (third from the left), country lead, Sanofi China and Lijun Xin (third from the right), CEO of JD Health at the cooperation launching ceremony
Dec 12, 2024|
JD Health Debuts Merck’s New Diabetes Medication GLUCOPHAGE® XR (Reduce Mass) Online in China
On December 10, JD Health, in collaboration with Merck, a globally renowned biopharmaceutical leader, began offering GLUCOPHAGE® XR (Reduce Mass), the metformin hydrochloride extended-release tablets, and became the first online pharmacy in China to provide the new antidiabetic medication developed by Merck. This launch signifies a major milestone in the partnership between JD Health and Merck, which is dedicated to enhancing the online availability and accessibility of innovative treatments for type 2 diabetes patients in China, thereby offering them a more convenient and effective medication experience.
GLUCOPHAGE® has been a cornerstone in the treatment of type 2 diabetes for over 60 years worldwide. The latest version of this medication is designed to enhance patient adherence by reducing the long-term burden of medication administration while maintaining its therapeutic benefits. The use of GSD sustained-release technology extends the time the medication remains in the stomach, reduces gastrointestinal irritation, and improves drug absorption. Additionally, the tablet is now smaller, has reduced volume by 30%, and has been transitioned from a capsule to a round shape, making it easier to swallow. It requires only once-daily administration, significantly enhancing patient convenience and safety.
To celebrate the online launch collaboration, JD Health and Merck hosted a special release event for the new medication at the 7th China International Import Expo in November. This event followed their partnership agreement in September, which also marked the opening of Merck China’s self-operated flagship store on JD.com.
With a large user base, robust supply chain, and rich medical service resources, JD Health has become a preferred partner to launch many chronic disease medications online. By seamlessly integrating online and offline resources, JD Health ensures that new drug information reaches the right users swiftly, offering convenient purchasing options and improving drug accessibility and usage efficiency. Additionally, JD Health’s extensive logistics network ensures timely and secure delivery of medications, enhancing user experience and building trust.
(vivian.yang@jd.com)
Nov 7, 2024|
CIIE 2024: JD.com to Expand Imports of Specialty Brands, Strengthen Healthcare Partnerships, and Enhance Logistics
At the 7th China International Import Expo (CIIE) on November 5, JD Super, the supermarket division of JD.com, announced a major initiative to broaden its selection of imported specialty. Over the next three years, JD Super plans to introduce over 1,000 new international brands to meet the increasing demand for high-quality, diverse imported goods.
Meeting the Growing Demand for Quality Imports
According to JD Worldwide’s “White Paper on 2024 China Cross-Border Consumption Trends,” more than 80% of Chinese consumers are interested in imported products, with many prioritizing authenticity, quality, and fast delivery. In response, JD has significantly expanded its range of international offerings. During the ongoing Singles’ Day Grand Promotion, sales of cross-border products have surged, with more than 600 brands experiencing a sales increase of over 100% compared to last year.
Strengthening High-Quality Food Partnerships
Demonstrating JD.com’s commitment to sourcing high-quality products, JD Super signed a new procurement agreement at CIIE with Huadong Foods and Teys, a major Australian beef brand under Cargill. Under this agreement, JD Super and Huadong Foods will procure $50 million of Teys beef throughout 2025. This partnership underscores JD’s strategy of collaborating with trusted suppliers to provide high-quality, affordable beef to Chinese consumers.
Delivering Authentic Global Goods Efficiently
JD Logistics has built a robust logistics network that spans bonded, direct mail, and overseas warehouses, facilitating fast deliveries of imported items across categories such as electronics, fashion, beauty, food, and baby products. In many major cities, delivery times have been reduced to under 48 hours.
For instance, JD Super’s partnership with Raub of Malaysia enables the import of Musang King durians, which are harvested at peak ripeness and air-shipped with cold chain logistics for delivery within 24 hours. Additionally, JD.com also secured an early supply of Chilean cherries, available since October, which can be delivered in as little as 30 minutes in many areas through JD NOW, its on-demand retail service.
JD.com’s “JD National Pavilions” program, which features over 150 country-themed flagship stores from more than 70 countries and regions, continues to be a cornerstone of its import strategy. Supported by embassies and reputable organizations, this initiative offers Chinese consumers access to premium products and cultural experiences from around the world. In April, JD launched the JD National Pavilion of Mali, introducing popular items like shea butter and garnering over 40,000 followers.
Expanding Healthcare and Logistics Partnerships
JD Health is also making strides at CIIE by strengthening partnerships with leading global healthcare companies, including Merck, Bayer, and Roche. As “China’s premier online health access point,” JD Health is committed to integrating digital and physical healthcare resources to improve access and convenience for patients.
Key collaborations include initiatives with Haleon to promote brain health and anti-aging for the “silver economy,” with MSD China on a digital diabetes management model, and with Teva Pharmaceuticals to provide patient education for conditions such as tardive dyskinesia (TD) and Huntington’s disease (HD).
On the logistics front, JD Logistics announced plans to double its overseas warehouse space by 2025 and expand its network of bonded and direct mail warehouses. JD Express now serves over 60 countries, enhancing cross-border delivery efficiency and supporting both brands and consumers.
Through these efforts, JD.com reaffirms its commitment to sourcing and delivering authentic, high-quality imported products to Chinese consumers, supported by an advanced supply chain that ensures a superior shopping experience.
(vivian.yang@jd.com)
First JD 618 Order Delivered by JD Robot in 4 Minutes
